Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1

Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1

Background: Shenmai Injection (SMI) has been widely used in the treatment of cardiovascular diseases and can reduce side effects when combined with chemotherapy drugs. However, the potential protective mechanism of SMI on the cardiotoxicity caused by anthracyclines has not been clear. Methods: We us...

Full description

Bibliographic Details
Main Authors: Xiaonan Zhang, Shichao Lv, Wanqin Zhang, Qiujin Jia, Lirong Wang, Yuejia Ding, Peng Yuan, Yaping Zhu, Longtao Liu, Yanyang Li, Junping Zhang
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Doxorubicin
Cardiotoxicity
Shenmai injection
Network pharmacology
MiR-30a/Beclin 1
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222100367X

Internet

http://www.sciencedirect.com/science/article/pii/S075333222100367X

Similar Items